Alnylam Pharmaceuticals | صافي الدخل



Net Income تغيير تاريخ
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.43B 298M 2025-06
Arrowhead Research USD -175241000 545.69M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Incyte USD 405M 246.8M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
Moderna USD -825000000 146M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 2.82B 371M 2024-12
PTC Therapeutics USD -64849000 931.41M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
Takeda JPY 124.24B 227.4B 2025-06
Tectonic Therapeutic USD -12373000 5.34M 2024-12
Ultragenyx Pharmaceutical USD -114951000 36.13M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06
Xencor USD -30825000 17.59M 2025-06


Alnylam Pharmaceuticals صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.